ECM
BNGO icon

ExodusPoint Capital Management’s Bionano Genomics BNGO Stock Holding History

ExodusPoint Capital Management’s Portfolio BNGO Stock Details BNGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-920
Closed -$337K – 1716
2023
Q2 		$337K Buy
+920
New +$415K ﹤0.01% 1491
2021
Q4 		– Sell
-22
Closed -$72K – 2181
2021
Q3 		$72K Buy
+22
New +$77K ﹤0.01% 1937
2021
Q1 		– Sell
-268
Closed -$496K – 2129
2020
Q4 		$496K Buy
+268
New +$100K ﹤0.01% 1259

Other funds holding BNGO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $149B AUM 24.71% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

ExodusPoint Capital Management's BNGO Position: Q3 2023 in Review

ExodusPoint Capital Management sold out of Bionano Genomics (BNGO) in Q3 2023, closing a stake of 920 shares — an estimated $337K sold.

ExodusPoint Capital Management first reported a position in BNGO in Q4 2020 and held it in 3 quarters. The position peaked at $496K in Q4 2020. 46 funds tracked by Wall St. Rank hold BNGO as of Q3 2023.

  • ExodusPoint Capital Management reported no remaining Bionano Genomics position as of Q3 2023 after selling out during the quarter.
  • ExodusPoint Capital Management sold 920 Bionano Genomics shares in Q3 2023, an estimated $337K.
  • ExodusPoint Capital Management first reported a position in Bionano Genomics in Q4 2020 and held it in 3 quarters.
  • ExodusPoint Capital Management's Bionano Genomics position peaked at $496K in Q4 2020.
  • 46 funds tracked by Wall St. Rank held Bionano Genomics as of Q3 2023.

Based on ExodusPoint Capital Management's 13F filing for Q3 2023, filed 13 Nov 2023.